KalshiScience and Technology
Will the FDA approve MDMA for PTSD?
MDMA for PTSD
Ends Jan 1, 2027
Bet NowDisclosure
18+ only. Event contracts carry significant risk and are not suitable for everyone, you can lose the entire amount you commit. Not available in all jurisdictions; restrictions and eligibility requirements apply.
Probability
- Before Jan 1, 2027997.9 VOL.Yes 14%No 86%14¢
- Before Jan 1, 2028761.4 VOL.Yes 39%No 61%39¢
- Before Jan 1, 20291.5K VOL.Yes 53%No 47%53¢
- Before Jan 1, 20302.4K VOL.Yes 49%No 51%49¢
- Before Jan 1, 20311.8K VOL.Yes 53%No 47%53¢
Rules Summary
If the FDA approves midomafetamine / MDMA for PTSD for marketing before Jan 1, 2027, then the market resolves to Yes.
Timeline and Payout
- Opened
- May 14, 2026, 2:00 AM
- Closes
- Jan 1, 2027, 4:59 AM
- Pays out
- 0.5 hours after close
Series KXFDAAPPROVE · Event KXFDAAPPROVE-MDMA · Market KXFDAAPPROVE-MDMA-27JAN01